Selected research
Industry Research
Plasma Collection and Processing Industry Research Report 2026
Market perspective
The global Plasma Collection and Processing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Plasma Collection and Processing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Plasma Collection and Processing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Plasma Collection and Processing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Plasma Collection and Processing include CSL Behring, Baxter, Grifols, Octapharma, Takeda, Octaphaarma, Kedrion, BPL and LFB Group, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Plasma Collection and Processing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Plasma Collection and Processing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Collection and Processing Market by Company
CSL Behring
Baxter
Grifols
Octapharma
Takeda
Octaphaarma
Kedrion
BPL
LFB Group
Tiantan Biological Products
Shanghai RAAS Blood Products
Hualan Biological
Pacific Shuanglin Bio-pharmacy
China Biologic Products
Plasma Collection and Processing Segment by Type
Single Plasma Collection Station
Other
Plasma Collection and Processing Segment by Application
Albumin
Immunoglobulin
Coagulation Factor
Plasma Collection and Processing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Collection and Processing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Collection and Processing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Collection and Processing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Plasma Collection and Processing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Plasma Collection Station
- Other
Applications
- Albumin
- Immunoglobulin
- Coagulation Factor
Companies covered
- CSL Behring
- Baxter
- Grifols
- Octapharma
- Takeda
- Octaphaarma
- Kedrion
- BPL
- LFB Group
- Tiantan Biological Products
- Shanghai RAAS Blood Products
- Hualan Biological
- Pacific Shuanglin Bio-pharmacy
- China Biologic Products
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Plasma Collection and Processing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single Plasma Collection Station
- 2.2.3 Other
- 2.3 Plasma Collection and Processing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Albumin
- 2.3.3 Immunoglobulin
- 2.3.4 Coagulation Factor
- 2.4 Assumptions and Limitations
3 Plasma Collection and Processing Breakdown Data by Type
- 3.1 Global Plasma Collection and Processing Historic Market Size by Type (2021-2026)
- 3.2 Global Plasma Collection and Processing Forecasted Market Size by Type (2027-2032)
4 Plasma Collection and Processing Breakdown Data by Application
- 4.1 Global Plasma Collection and Processing Historic Market Size by Application (2021-2026)
- 4.2 Global Plasma Collection and Processing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Plasma Collection and Processing Market Perspective (2021-2032)
- 5.2 Global Plasma Collection and Processing Growth Trends by Region
- 5.2.1 Global Plasma Collection and Processing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Plasma Collection and Processing Historic Market Size by Region (2021-2026)
- 5.2.3 Plasma Collection and Processing Forecasted Market Size by Region (2027-2032)
- 5.3 Plasma Collection and Processing Market Dynamics
- 5.3.1 Plasma Collection and Processing Industry Trends
- 5.3.2 Plasma Collection and Processing Market Drivers
- 5.3.3 Plasma Collection and Processing Market Challenges
- 5.3.4 Plasma Collection and Processing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Plasma Collection and Processing Players by Revenue
- 6.1.1 Global Top Plasma Collection and Processing Players by Revenue (2021-2026)
- 6.1.2 Global Plasma Collection and Processing Revenue Market Share by Players (2021-2026)
- 6.2 Global Plasma Collection and Processing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Plasma Collection and Processing Head Office and Area Served
- 6.4 Global Plasma Collection and Processing Players, Product Type & Application
- 6.5 Global Plasma Collection and Processing Manufacturers Established Date
- 6.6 Global Plasma Collection and Processing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Plasma Collection and Processing Market Size (2021-2032)
- 7.2 North America Plasma Collection and Processing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Plasma Collection and Processing Market Size by Country (2021-2026)
- 7.4 North America Plasma Collection and Processing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Plasma Collection and Processing Market Size (2021-2032)
- 8.2 Europe Plasma Collection and Processing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Plasma Collection and Processing Market Size by Country (2021-2026)
- 8.4 Europe Plasma Collection and Processing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Plasma Collection and Processing Market Size (2021-2032)
- 9.2 Asia-Pacific Plasma Collection and Processing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Plasma Collection and Processing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Plasma Collection and Processing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Plasma Collection and Processing Market Size (2021-2032)
- 10.2 South America Plasma Collection and Processing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Plasma Collection and Processing Market Size by Country (2021-2026)
- 10.4 South America Plasma Collection and Processing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Plasma Collection and Processing Market Size (2021-2032)
- 11.2 Middle East & Africa Plasma Collection and Processing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Plasma Collection and Processing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Plasma Collection and Processing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CSL Behring
- 12.1.1 CSL Behring Company Information
- 12.1.2 CSL Behring Business Overview
- 12.1.3 CSL Behring Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.1.4 CSL Behring Plasma Collection and Processing Product Portfolio
- 12.1.5 CSL Behring Recent Developments
- 12.2 Baxter
- 12.2.1 Baxter Company Information
- 12.2.2 Baxter Business Overview
- 12.2.3 Baxter Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.2.4 Baxter Plasma Collection and Processing Product Portfolio
- 12.2.5 Baxter Recent Developments
- 12.3 Grifols
- 12.3.1 Grifols Company Information
- 12.3.2 Grifols Business Overview
- 12.3.3 Grifols Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.3.4 Grifols Plasma Collection and Processing Product Portfolio
- 12.3.5 Grifols Recent Developments
- 12.4 Octapharma
- 12.4.1 Octapharma Company Information
- 12.4.2 Octapharma Business Overview
- 12.4.3 Octapharma Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.4.4 Octapharma Plasma Collection and Processing Product Portfolio
- 12.4.5 Octapharma Recent Developments
- 12.5 Takeda
- 12.5.1 Takeda Company Information
- 12.5.2 Takeda Business Overview
- 12.5.3 Takeda Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.5.4 Takeda Plasma Collection and Processing Product Portfolio
- 12.5.5 Takeda Recent Developments
- 12.6 Octaphaarma
- 12.6.1 Octaphaarma Company Information
- 12.6.2 Octaphaarma Business Overview
- 12.6.3 Octaphaarma Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.6.4 Octaphaarma Plasma Collection and Processing Product Portfolio
- 12.6.5 Octaphaarma Recent Developments
- 12.7 Kedrion
- 12.7.1 Kedrion Company Information
- 12.7.2 Kedrion Business Overview
- 12.7.3 Kedrion Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.7.4 Kedrion Plasma Collection and Processing Product Portfolio
- 12.7.5 Kedrion Recent Developments
- 12.8 BPL
- 12.8.1 BPL Company Information
- 12.8.2 BPL Business Overview
- 12.8.3 BPL Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.8.4 BPL Plasma Collection and Processing Product Portfolio
- 12.8.5 BPL Recent Developments
- 12.9 LFB Group
- 12.9.1 LFB Group Company Information
- 12.9.2 LFB Group Business Overview
- 12.9.3 LFB Group Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.9.4 LFB Group Plasma Collection and Processing Product Portfolio
- 12.9.5 LFB Group Recent Developments
- 12.10 Tiantan Biological Products
- 12.10.1 Tiantan Biological Products Company Information
- 12.10.2 Tiantan Biological Products Business Overview
- 12.10.3 Tiantan Biological Products Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.10.4 Tiantan Biological Products Plasma Collection and Processing Product Portfolio
- 12.10.5 Tiantan Biological Products Recent Developments
- 12.11 Shanghai RAAS Blood Products
- 12.11.1 Shanghai RAAS Blood Products Company Information
- 12.11.2 Shanghai RAAS Blood Products Business Overview
- 12.11.3 Shanghai RAAS Blood Products Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.11.4 Shanghai RAAS Blood Products Plasma Collection and Processing Product Portfolio
- 12.11.5 Shanghai RAAS Blood Products Recent Developments
- 12.12 Hualan Biological
- 12.12.1 Hualan Biological Company Information
- 12.12.2 Hualan Biological Business Overview
- 12.12.3 Hualan Biological Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.12.4 Hualan Biological Plasma Collection and Processing Product Portfolio
- 12.12.5 Hualan Biological Recent Developments
- 12.13 Pacific Shuanglin Bio-pharmacy
- 12.13.1 Pacific Shuanglin Bio-pharmacy Company Information
- 12.13.2 Pacific Shuanglin Bio-pharmacy Business Overview
- 12.13.3 Pacific Shuanglin Bio-pharmacy Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.13.4 Pacific Shuanglin Bio-pharmacy Plasma Collection and Processing Product Portfolio
- 12.13.5 Pacific Shuanglin Bio-pharmacy Recent Developments
- 12.14 China Biologic Products
- 12.14.1 China Biologic Products Company Information
- 12.14.2 China Biologic Products Business Overview
- 12.14.3 China Biologic Products Revenue in Plasma Collection and Processing Business (2021-2026)
- 12.14.4 China Biologic Products Plasma Collection and Processing Product Portfolio
- 12.14.5 China Biologic Products Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst